Description
API: Testosterone Cypionate 250 mg/ml
Usage: 3rd Degree CYPIONE-T250 is long ester variant of Testosterone, ideally suited for lean gaining and bulking cycles and generally combined with other gaining steroids such as Boldenone or Deca Durabolin. Its longer half-life and slow-release allow longer stay in the body and less frequent injection.
Dosage
Cycle Type | Dosage |
---|---|
Beginner | 250-500mg Every week |
Intermediate | 500-750mg Every week |
Advanced | 750-1000mg Every week |
Testosterone Cypionate Stacking
Cycle Type | Dosage | Duration |
---|---|---|
Beginner | ANDROXY-50 50-100mg ED And/or DIANABOL 50mg ED |
12-16 weeks |
Intermediate | ANDROXY-50 50-100mg ED And/Or DIANABOL 50mg ED DECA-D250 250-500mg EW BOLD-E250 250-500mg EW |
12-16 weeks |
Advanced | ANDROXY-50 50-100mg ED And/Or DIANABOL 50-100mg ED DECA-D250 500-700mg EW BOLD-E250 500-700mg EW TRENBOL-A100 400-600mg EW |
12-16 weeks |
Cycle Support**
Cycle Type | Dosage |
---|---|
Beginner | Tamoxifen Citrate 10mg EOD |
Intermediate | Tamoxifen Citrate 10mg ED |
Advanced | Letrozole 1mg Twice/Thrice EW |
** To reduce side effects and damages caused to the endocrine system, liver Heart, sexual health, etc.
PCT FOR CYPIONE-T250 CYCLE
Cycle Type | Dosage | Duration |
---|---|---|
Beginner | Tamoxifen Citrate 10mg EOD Clomid 50mg EOD |
30 days |
Intermediate | Tamoxifen Citrate 20mg ED HCG 1000-2000iu EW Clomid 50mg ED |
30 days |
Advanced | Letrozole 1mg Twice/Thrice EW HCG 1000-2000iu EW Clomid 50mg ED |
30 days |
Side Effects, Overdosage & Contraindications
Androgenic side effects such as oily skin, acne, seborrhoea, increased facial/body hair growth, scalp hair loss, and virilization may occur. Estrogenic side effects such as gynecomastia and fluid retention can also occur.
STOP THE CYCLE AND SEEK EXPERT GUIDANCE IN CASE OF SEVERE SIDE EFFECTS.
Disclaimer: Above mentioned information is for educational and references purposes only. Consult a registered healthcare professional for a proper course of medication.
Reviews
There are no reviews yet.